reglab/statecodes huggingface dataset:
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2592 - Dispensing pharmacist required to make record of dispensed biological product; recordation options; record deemed notice to prescriber; alternative types of notice; exceptions.

1. Except as otherwise provided in subsections 3 and 4, within 3 business days after dispensing a biological product, the dispensing pharmacist or his or her designee shall make an entry of the specific product provided to the patient that includes, without limitation, the name of the product and its manufacturer. The record must be electronically accessible by the prescribing practitioner through:
(a) An interoperable electronic health records system;
(b) Electronic prescribing technology;
(c) A pharmacy benefit management system; or
(d) A pharmacy record.
2. An electronic record of the dispensing of a biological product made pursuant to subsection 1 is presumed to provide notice to the prescriber of the dispensing of the product.
3. Except as otherwise provided in subsection 4, if an electronic record of the dispensing of a biological product is not made pursuant to subsection 1, the dispensing pharmacist or his or her designee shall, within 3 business days after dispensing the biological product, give notice of the biological product to the prescriber by facsimile, telephone, electronic transmission or other available means.
4. Notice of the dispensing of a biological product pursuant to subsection 1 or 3 is not required if:
(a) There is no interchangeable biological product for the biological product prescribed; or
(b) A prescription for a refill is not changed from the product dispensed on the prior filling of the prescription.
5. As used in this section, "electronic health record" has the meaning ascribed to it in 42 U.S.C. § 17921(5).
(Added to NRS by 2017, 633)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2595 - Liability of pharmacist or practitioner.

A pharmacist or practitioner who selects a drug or interchangeable biological product for substitution assumes no greater civil liability than he or she assumes by filling the prescription with the drug under its brand name or the prescribed biological product.
(Added to NRS by 1979, 1349; A 1989, 1122; 2017, 636)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2596 - Board required to maintain link on Internet website to certain list of licensed biological products.

The Board shall maintain a link on its Internet website to the
Purple Book: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations
, published by the Food and Drug Administration.
(Added to NRS by 2017, 633)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2597 - Use of list of biologically equivalent drugs or interchangeable biological products.

A pharmacist or practitioner who proposes to make any substitution must have made use of a list of biologically equivalent drugs or interchangeable biological products approved by the United States Food and Drug Administration.
(Added to NRS by 1979, 1349; A 1989, 1122; 1993, 635; 2017, 636)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2627 - Requirements for contents of and submission of collaborative practice agreement; expiration and renewal of agreement.

1. A collaborative practice agreement must be signed by each practitioner and pharmacist who enter into the agreement and submitted to the Board in written and electronic form. A collaborative practice agreement must include:
(a) A description of the types of decisions concerning the management of drug therapy that the pharmacist is authorized to make, which may include a specific description of the diseases and drugs for which the pharmacist is authorized to manage drug therapy;
(b) A detailed explanation of the procedures that the pharmacist must follow when engaging in the collaborative practice of pharmacy, including, without limitation, the manner in which the pharmacist must document decisions concerning treatment and care in accordance with subsection 6 of NRS 639.2623, report such decisions to the practitioner and receive feedback from the practitioner;
(c) The procedure by which the pharmacist will notify the practitioner of an adverse event concerning the health of the patient;
(d) The procedure by which the practitioner will provide the pharmacist with a diagnosis of the patient and any other medical information necessary to carry out the patient’s drug therapy management;
(e) A description of the means by which the practitioner will monitor clinical outcomes of a patient and intercede when necessary to protect the health of the patient or accomplish the goals of the treatment prescribed for the patient;
(f) Authorization for the practitioner to override the agreement if necessary to protect the health of the patient or accomplish the goals of the treatment prescribed for the patient;
(g) Authorization for either party to terminate the agreement by written notice to the other party, which must include, without limitation, written notice to the patient that informs the patient of the procedures by which he or she may continue drug therapy;
(h) The effective date of the agreement;
(i) The date by which a review must be conducted pursuant to subsection 2 for the renewal of the agreement, which must not be later than the expiration date of the agreement;
(j) The address of the location where the records described in subsection 6 of NRS 639.2623 will be maintained; and
(k) The process by which the pharmacist will obtain the informed, written consent required by subsection 7 of NRS 639.2623.
2. A collaborative practice agreement must expire not later than 1 year after the date on which the agreement becomes effective. The parties to a collaborative practice agreement may renew the agreement after reviewing the agreement and making any necessary revisions.
(Added to NRS by 2017, 2520; A 2021, 1662)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2629 - Written guidelines and protocols authorizing collaborative drug therapy management: Required provisions; regulations.

1. Written guidelines and protocols developed by a registered pharmacist in collaboration with a practitioner which authorize collaborative drug therapy management must include, without limitation:
(a) A description of the types of decisions concerning the management of drug therapy that the pharmacist is authorized to make, including, without limitation:
(1) A specific description of the diseases, drugs and categories of drugs covered by the guidelines; and
(2) The types of decisions that the pharmacist is authorized to make for each disease, drug or category of drugs;
(b) The training that the pharmacist is required to complete;
(c) The procedures that the pharmacist is required to follow when initiating or modifying drug therapy or making other therapeutic decisions, including, without limitation:
(1) Criteria that the pharmacist is required to use when making therapeutic decisions; and
(2) Procedures for documenting therapeutic decisions and reporting such decisions to the practitioner; and
(d) Procedures for the practitioner to provide feedback concerning therapeutic decisions to each pharmacist who is a party to the agreement.
2. The Board may adopt regulations which prescribe additional requirements for written guidelines and protocols developed pursuant to this section.
(Added to NRS by 2011, 3077; A 2017, 2522; 2021, 1662)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.263 - False or misleading advertising.

No registered pharmacist or owner of any pharmacy licensed under the provisions of this chapter may make, disseminate or cause to be made or disseminated before the public in this state, in any newspaper or other publication, or any advertising device, or in any other manner or means whatever, any statement concerning prices or services, professional or otherwise, which is untrue or misleading, and which is known, or which by the exercise of reasonable care should be known, to be false or misleading.
(Added to NRS by 1967, 1663)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.264 - Prohibition against unearned rebate, refund or other consideration for referrals.

1. No registered pharmacist, or owner of any pharmacy licensed under the provisions of this chapter, may offer, deliver or pay any unearned rebate, refund, commission, preference, patronage dividend, discount or other unearned consideration to any person, whether in the form of money or otherwise, as compensation or inducement to such person for referring prescriptions, patients, clients or customers to such pharmacist or pharmacy, irrespective of any membership, proprietary interest or co-ownership in or with any person by whom such prescriptions, patients, clients or customers are referred.
2. The furnishing to a practitioner by a pharmacist or a pharmacy of prescription blanks bearing the name or name and address of any pharmacy is an unearned rebate and an inducement to refer patients to such pharmacist or pharmacy.
(Added to NRS by 1967, 1663; A 1979, 1695)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2655 - Use of computerized mechanical equipment to perform act required to be performed by pharmacist.

For the purposes of this chapter and chapters 453 and 454 of NRS, any act which is required to be performed by a pharmacist may be performed with the use of computerized mechanical equipment in accordance with the regulations adopted by the Board.
(Added to NRS by 1995, 289)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.266 - Communication of information to patient or person caring for patient.

1. Upon receipt of a prescription and after review of the patient’s record, a pharmacist shall communicate matters which will enhance therapy through drugs with the patient or a person caring for the patient. The communication must include appropriate elements of counseling for the patient, as established in regulations adopted by the Board. The communication must be in person if practicable, or by telephone or in writing if the patient or the person caring for the patient is not present at the pharmacy.
2. Additional information may be used to supplement counseling when appropriate, including leaflets, pictogram labels, video programs and other such information.
3. Counseling is not required for inpatients of a hospital or a licensed health care facility where administration of drugs is provided.
(Added to NRS by 1993, 2154)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2665 - Required posting or provision of written instructions relating to safe disposal of unused drugs by retail community pharmacy; penalties.

1. Each retail community pharmacy in this State shall post in a conspicuous place on the premises of the pharmacy or provide, upon the request of any person, written instructions concerning the safe disposal of unused drugs.
2. Notwithstanding any provision of this chapter to the contrary, upon a violation of subsection 1, the holder of a license of a retail community pharmacy and any pharmacist employed by the pharmacy are not:
(a) Guilty of a misdemeanor or felony; or
(b) Subject to:
(1) The suspension or revocation of a certificate, license or permit issued to the retail community pharmacy or pharmacist; or
(2) Probation.
3. Notwithstanding any provision of this chapter to the contrary, upon a violation of subsection 1, only the holder of a license of a retail community pharmacy may be disciplined by the Board, and only by one or both of the following methods:
(a) Public reprimand; or
(b) Imposition of a fine not to exceed $200 against the licensee. A fine may be imposed against the holder of a license of a retail community pharmacy pursuant to this section not more than once every 6 months.
4. As used in this section, "retail community pharmacy" means a pharmacy that is licensed by the Board and dispenses drugs directly to the general public at retail prices. The term does not include:
(a) A pharmacy that dispenses prescription medications to patients solely through the mail;
(b) A nonprofit pharmacy designated by the Board pursuant to NRS 639.2676;
(c) An institutional pharmacy;
(d) A pharmacy in a correctional institution; or
(e) A pharmacy owned or operated by a governmental entity.
(Added to NRS by 2017, 2093)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.267 - Return, reissuance or transfer of unused drugs: Drugs packaged in unit doses generally; regulations.

1. As used in this section, "unit dose" means that quantity of a drug which is packaged as a single dose.
2. A pharmacist who provides a regimen of drugs in unit doses to a patient in a facility for skilled nursing or facility for intermediate care as defined in chapter 449 of NRS may credit the person or agency which paid for the drug for any unused doses. The pharmacist may return the drugs to the dispensing pharmacy, which may reissue the drugs to fill other prescriptions or transfer the drugs in accordance with the provisions of NRS 449.2485.
3. Except schedule II drugs specified in or pursuant to chapter 453 of NRS and except as otherwise provided in NRS 433.801, 435.700, 449.2485, 638.200, 639.2675 and 639.2676, unit doses packaged in ampules or vials which do not require refrigeration may be returned to the pharmacy which dispensed them. The Board shall, by regulation, authorize the return of any other type or brand of drug which is packaged in unit doses if the Food and Drug Administration has approved the packaging for that purpose.
(Added to NRS by 1979, 981; A 1981, 840; 1985, 1769; 2003, 1374; 2009, 1090; 2011, 834; 2013, 3068)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2675 - Return, reissuance or transfer of unused drugs: Drugs dispensed by pharmacy to offender in correctional institution; written procedures for returning; regulations.

1. A prescription drug that is dispensed by a pharmacy to an offender incarcerated in a correctional institution, but will not be used by that offender, may be returned to that dispensing pharmacy for the purpose of reissuing the drug to fill other prescriptions for offenders incarcerated in that correctional institution or for the purposes of transferring the drug to a nonprofit pharmacy designated by the Board pursuant to NRS 639.2676 if:
(a) The drug is not a controlled substance;
(b) The drug is dispensed in a unit dose, in individually sealed doses or in a bottle that is sealed by the manufacturer of the drug;
(c) The drug is returned unopened and sealed in the original manufacturer’s packaging or bottle;
(d) The usefulness of the drug has not expired;
(e) The packaging or bottle contains the expiration date of the usefulness of the drug; and
(f) The name of the patient for whom the drug was originally prescribed, the prescription number and any other identifying marks are obliterated from the packaging or bottle before the return of the drug.
2. A pharmacy to which a drug is returned pursuant to this section may:
(a) Reissue the drug to fill other prescriptions for offenders incarcerated in the same correctional institution if the registered pharmacist of the pharmacy determines that the drug is suitable for that purpose in accordance with standards adopted by the Board pursuant to subsection 5; or
(b) Transfer the drug to a nonprofit pharmacy designated by the Board pursuant to NRS 639.2676.
3. No drug that is returned to a dispensing pharmacy pursuant to this section may be used to fill other prescriptions more than one time.
4. The director of a correctional institution shall adopt written procedures for returning drugs to a dispensing pharmacy pursuant to this section. The procedures must:
(a) Provide appropriate safeguards for ensuring that the drugs are not compromised or illegally diverted during their return.
(b) Require the maintenance and retention of such records relating to the return of such drugs as are required by the Board.
(c) Be approved by the Board.
5. The Board shall adopt such regulations as are necessary to carry out the provisions of this section including, without limitation, requirements for:
(a) Returning and reissuing such drugs pursuant to the provisions of this section.
(b) Transferring drugs to a nonprofit pharmacy pursuant to the provisions of this section and NRS 639.2676.
(c) Maintaining records relating to the return and the use of such drugs to fill other prescriptions.
6. As used in this section, "correctional institution" means an institution or facility operated by the Department of Corrections.
(Added to NRS by 2003, 1373; A 2009, 1090)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.270 - Sales of unrestricted drugs, medicines, remedies, poisons or chemicals by grocers and dealers.

Any drug, medicine, remedy, poison or chemical, the sale of which is not otherwise restricted as provided by this chapter or NRS 453.530, and any patent or proprietary medicine, may be sold by grocers and dealers generally without restriction when prepared and sold in original and unbroken packages and, if poisonous, labeled with the official poison labels and sold in accordance with the requirements of the Federal Food, Drug and Cosmetic Act.
[Part 18:286:1913; A 1925, 236; 1947, 667; 1949, 554; 1951, 290; 1953, 588]—(NRS A 1967, 1650; 2017, 1187)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.275 - Computer or other electronic device provided to practitioner by pharmacy or insurer.

A pharmacy or insurer may provide to a practitioner a computer or any other electronic device, including, without limitation, any software or equipment required for the computer or device if the computer or other electronic device is capable of transmitting data to any pharmacy in this state.
(Added to NRS by 2001, 834)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2801 - Requirements for labeling containers for prescribed drugs.

Unless specified to the contrary in writing on the prescription by the prescribing practitioner, all prescriptions filled by any practitioner must be dispensed in a container to which is affixed a label or other device which clearly shows:
1. The date.
2. The name, address and prescription serial number of the practitioner who filled the prescription.
3. The names of the prescribing practitioner and of the person for whom prescribed.
4. The number of dosage units.
5. The symptom or purpose for which the drug is prescribed, if included by the practitioner pursuant to NRS 639.2352.
6. Specific directions for use given by the prescribing practitioner.
7. The expiration date of the effectiveness of the drug or medicine dispensed, if that information is included on the original label of the manufacturer of that drug or medicine. If the expiration date specified by the manufacturer is not less than 1 year after the date of dispensing, the practitioner may use a date that is 1 year after the date of dispensing as the expiration date.
8. The proprietary or generic name of the drug or medicine as written by the prescribing practitioner.
9. The strength of the drug or medicine.
The label must contain the warning:
Caution: Do not use with alcohol or nonprescribed drugs without consulting the prescribing practitioner.
(Added to NRS by 1973, 265; A 1975, 224; 1979, 1695; 1989, 1122; 1991, 1953; 2003, 452; 2005, 1619; 2007, 659)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.28013 - Duty to provide certain information for prescribed drugs in English and certain other languages upon request; exception; posting of rights and list of languages; regulations; civil liability related to contracts for translation.

1. Each pharmacy, except for an institutional pharmacy, shall, upon the request of a prescribing practitioner, a patient or an authorized representative of a patient, provide the information required by subsection 6 of NRS 639.2801 in English and any language in which the information is required to be provided pursuant to subsection 3.
2. Each pharmacy subject to the requirements of subsection 1 shall post in a conspicuous place:
(a) Notice of the rights of a patient to request information in a language other than English pursuant to subsection 1; and
(b) A list of every language in which such information is available.
3. The Board shall adopt regulations prescribing every language in which a pharmacy is required to provide information required by NRS 639.2801. The languages in which a pharmacy is required to provide such information must be specified by the regulations adopted by the Board pursuant to this section based on demographic trends and projections.
4. The Board may adopt such other regulations as are necessary to carry out the provisions of this section.
5. If a pharmacy enters into a contract with a third party for the translation of the information that the pharmacy is required to provide pursuant to this section, the pharmacy and any employee of the pharmacy are not liable in any civil action for any injury resulting from the translation by the third party which is not the result of negligence, recklessness or deliberate misconduct of the pharmacy or employee.
(Added to NRS by 2021, 861)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.28015 - Retail community pharmacy required to provide notice of availability of prescription reader; provision of prescription reader; exceptions.

1. Except as otherwise provided in subsection 2, a retail community pharmacy shall notify each person to whom a drug is dispensed that a prescription reader is available to the person. The retail community pharmacy shall, upon the request of a person to whom a drug is dispensed:
(a) Provide a prescription reader to the person to whom the drug is dispensed to use for at least the duration of the prescription and attach to the container of the drug a label or other device that is capable of conveying the information prescribed in NRS 639.2801 to a person using the prescription reader; or
(b) Provide directions or advice to the person on obtaining a prescription reader appropriate to his or her visual or print impairment.
2. The requirements of subsection 1 do not apply if:
(a) The drug is not dispensed in a container to which is affixed a label or other device pursuant to NRS 639.2801; or
(b) The drug is dispensed through the mail.
3. As used in this section:
(a) "Prescription reader" means a device designed to convey audibly the information contained on the label or other device affixed to the container of a prescription drug to a person who is visually impaired or otherwise would have difficulty reading the label.
(b) "Retail community pharmacy" means a pharmacy that is licensed by the Board and dispenses drugs directly to the general public at retail prices. The term does not include:
(1) A pharmacy that dispenses prescription medications to patients solely through the mail;
(2) A nonprofit pharmacy designated by the Board pursuant to NRS 639.2676;
(3) An institutional pharmacy;
(4) A pharmacy in a correctional institution; or
(5) A pharmacy operated by a governmental entity.
(Added to NRS by 2017, 484)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2802 - Availability of information concerning prices of prescriptions.

In addition to any applicable requirements set forth in NRS 439B.600 to 439B.695, inclusive, prescription price information must be made available, upon request, by a pharmacist or practitioner who dispenses drugs.
(Added to NRS by 1973, 265; A 1989, 1123; 2007, 3140)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.28025 - Notice of availability of list of prices for drugs and professional services to be posted.

In addition to any applicable requirements set forth in NRS 439B.600 to 439B.695, inclusive, every practitioner who dispenses drugs shall post on the premises in a place conspicuous to customers and easily accessible and readable by customers a notice, provided by the Board, advising customers that a price list of drugs and professional services is available to them upon request.
(Added to NRS by 1979, 355; A 1989, 1123; 2007, 3140)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2804 - Filling prescriptions for amygdalin and procaine hydrochloride.

1. A prescription for the substance having the trade name "laetrile" shall be considered as an order for the substance by its generic name, amygdalin. The prescription may be filled with "laetrile" or its generic equivalent.
2. A prescription for the substance having the trade name "Gerovital H3" shall be considered as an order for procaine hydrochloride with preservatives and stabilizers, and the order may be filled using similar products manufactured under other trade names.
(Added to NRS by 1977, 1647)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2805 - Substances licensed for manufacture in Nevada: Filling prescriptions; labeling of containers.

1. A pharmacist or practitioner is not subject to any penalty for filling a prescription for a substance licensed for manufacture in this state if the prescription is issued to a patient by his or her practitioner.
2. If a substance licensed for manufacture in this state has not been approved as a drug by the Food and Drug Administration, the label or other device affixed to its container must so state and the label must further state that the State of Nevada has not approved the substance.
(Added to NRS by 1977, 1647; A 1983, 151; 1989, 1123; 1991, 793)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2806 - Parenteral solutions: Limitation on sale and dispensing.

A parenteral solution which is used by a patient in his or her home or in a facility for the dependent or a medical facility, other than a hospital as defined in NRS 449.012, may only be sold or dispensed:
1. By a pharmacy licensed in this state or a practitioner;
2. If the date of expiration is on its label; and
3. If a practitioner, registered pharmacist and a registered nurse are available at all times for immediate assistance to the patient in case of any pharmaceutical problems encountered in its use.
(Added to NRS by 1985, 867; A 1995, 295)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2807 - Parenteral solutions: Compounding, packaging and labeling; regulations.

1. Any parenteral for use in a home or a facility for the dependent or a medical facility, other than a hospital as defined in NRS 449.012, must be compounded, packaged and labeled:
(a) By a registered pharmacist in a pharmacy or a practitioner licensed in this state. The practitioner shall ensure that the parenterals are delivered to the patient and are not available for use after the date of expiration.
(b) Pursuant to regulations adopted by the Board.
2. To maintain the stability of parenteral solutions, to prevent their contamination and that of the personnel of the practitioner and to ensure the quality and continuity of care for patients, the Board shall adopt regulations, to include:
(a) The procedures for the compounding, packaging, replacement and disposal of parenteral solutions;
(b) The conditions under which those solutions must be prepared, stored and delivered;
(c) The equipment required for the preparation, sterilization and storage of those solutions and the maintenance and cleaning of that equipment;
(d) The procedures for the proper disposal of any material used in the preparation of those solutions;
(e) The procedures for maintaining records and clinical monitoring of patients;
(f) The education and training of persons employed by practitioners; and
(g) The requirements for the education of patients relating to the use of parenterals.
(Added to NRS by 1985, 867; A 1989, 1123; 1995, 295)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.28075 - Requirements for filling prescription for drug used for contraception; refills; exceptions.

1. Except as otherwise provided in subsection 2, pursuant to a valid prescription or order for a drug to be used for contraception or its therapeutic equivalent which has been approved by the Food and Drug Administration, a pharmacist shall:
(a) If the patient is not currently using the drug or its therapeutic equivalent, dispense up to a 3-month supply of the drug or therapeutic equivalent or any amount designated by the prescription or order, whichever is less.
(b) If the drug or therapeutic equivalent has only been dispensed to the patient once pursuant to paragraph (a), dispense up to a 9-month supply of the drug or therapeutic equivalent, any amount designated by the prescription or order or any amount which covers the remainder of the plan year if the patient is covered by a health care plan, whichever is less.
(c) For a refill in a plan year following the initial dispensing of a drug or therapeutic equivalent pursuant to paragraphs (a) and (b), dispense a 12-month supply of the drug or therapeutic equivalent, any amount designated by the prescription or order or any amount which covers the remainder of the plan year if the patient is covered by a health care plan, whichever is less.
2. A pharmacist is not required to dispense an amount of a drug to be used for contraception or its therapeutic equivalent for which the patient is unable or unwilling to pay any applicable charge, copayment or coinsurance due to the pharmacy.
3. As used in this section:
(a) "Health care plan" means a policy, contract, certificate or agreement offered or issued by an insurer, including without limitation, the State Plan for Medicaid, to provide, deliver, arrange for, pay for or reimburse any of the costs of health care services.
(b) "Plan year" means the year designated in the evidence of coverage of a health care plan in which a person is covered by such plan.
(c) "Therapeutic equivalent" means a drug which:
(1) Contains an identical amount of the same active ingredients in the same dosage and method of administration as another drug;
(2) Is expected to have the same clinical effect when administered to a patient pursuant to a prescription or order as another drug; and
(3) Meets any other criteria required by the Food and Drug Administration for classification as a therapeutic equivalent.
(Added to NRS by 2017, 1803, 3930; A 2023, 2092)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.28077 - Self-administered hormonal contraceptive: Establishment of protocol for dispensing; regulations.

1. The Board shall adopt regulations establishing a protocol for dispensing a self-administered hormonal contraceptive, as authorized by NRS 639.28078. Those regulations must include, without limitation:
(a) Requirements governing the information that must be included in a record concerning the dispensing of the self-administered hormonal contraceptive in addition to the information required by NRS 639.28078; and
(b) The amount of time that such a record must be maintained by the dispensing pharmacist or his or her employer.
2. The Board shall adopt regulations that prescribe:
(a) A risk assessment questionnaire that must be provided to a patient who requests a self-administered hormonal contraceptive pursuant to NRS 639.28078.
(b) The information that must be provided in writing to a patient to whom a self-administered hormonal contraceptive is dispensed pursuant to NRS 639.28078, which may include, without limitation, information concerning:
(1) The importance of obtaining recommended tests and screening from the patient’s attending provider or another qualified provider of health care who specializes in women’s health;
(2) The effectiveness of long-acting, reversible contraceptives as an alternative to self-administered hormonal contraceptives;
(3) When to seek emergency medical services as a result of administering a self-administered hormonal contraceptive; and
(4) The risk of contracting a sexually transmitted infection and ways to reduce that risk.
3. As used in this section:
(a) "Attending provider" means a provider of health care who provides or has provided care to the patient.
(b) "Provider of health care" has the meaning ascribed to it in NRS 629.031.
(Added to NRS by 2021, 3268)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.28079 - Medication-assisted treatment of opioid use disorder: Conditions under which pharmacist registered with Board is authorized to assess and counsel patient and prescribe and dispense drug; regulations regarding registration and establishment of protocol.

1. To the extent authorized by federal law, a pharmacist who registers with the Board to engage in the activity authorized by this section may, in accordance with the requirements of the protocol prescribed pursuant to subsection 2:
(a) Assess a patient to determine whether:
(1) The patient has an opioid use disorder; and
(2) Medication-assisted treatment would be appropriate for the patient;
(b) Counsel and provide information to the patient concerning evidence-based treatment for opioid use disorders, including, without limitation, medication-assisted treatment; and
(c) Prescribe and dispense a drug for medication-assisted treatment.
2. The Board shall adopt regulations:
(a) Prescribing the requirements to register with the Board to engage in the activity authorized by this section; and
(b) Establishing a protocol for the actions authorized by this section.
3. As used in this section, "medication-assisted treatment" means treatment for an opioid use disorder using medication approved by the United States Food and Drug Administration for that purpose.
(Added to NRS by 2023, 2367)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2808 - Performance of blood glucose test by registered pharmacist or registered intern pharmacist.

A registered pharmacist or a registered intern pharmacist may perform a blood glucose test using devices for monitoring approved by the Food and Drug Administration for use in the home. The performance of such a test must be in compliance with standards of practice recommended by the American Association of Diabetes Educators or its successor organization.
(Added to NRS by 2009, 760)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.28085 - Certain drugs for preventing acquisition of human immunodeficiency virus: Ordering and performing necessary laboratory tests for therapy; prescribing, dispensing and administering; coverage by liability insurance; protocol; regulations.

1. To the extent authorized by federal law, a pharmacist who meets the requirements prescribed by the Board pursuant to subsection 2 may, in accordance with the requirements of the protocol prescribed pursuant to subsection 2:
(a) Order and perform laboratory tests that are necessary for therapy that uses a drug approved by the United States Food and Drug Administration for preventing the acquisition of human immunodeficiency virus; and
(b) Prescribe, dispense and administer any drug described in paragraph (a) to a patient.
2. The Board shall adopt regulations:
(a) Requiring a pharmacist who takes the actions authorized by this section to be covered by adequate liability insurance, as determined by the Board; and
(b) Establishing a protocol for the actions authorized by this section.
(Added to NRS by 2021, 3201)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.28095 - Pharmacist employed by off-site pharmaceutical service provider to provide remote chart order processing services to hospital or correctional institution required to be registered with Board; duty of off-site pharmaceutical service provider to ensure compliance.

1. A pharmacist who is employed by an off-site pharmaceutical service provider to provide remote chart order processing services to a hospital or correctional institution must be registered to practice pharmacy in this State.
2. An off-site pharmaceutical service provider shall ensure that any remote chart order processing services that are provided to a hospital or correctional institution in this State are provided by a pharmacist who complies with the requirements of subsection 1.
3. As used in this section:
(a) "Chart order processing services" means nondispensary pharmaceutical services that are provided by a pharmacy to a hospital or correctional institution, including, without limitation:
(1) Receiving, interpreting and clarifying a chart order received from a hospital or correctional institution;
(2) Entering information regarding a chart order into the computerized data system of a hospital or correctional institution;
(3) Interpreting clinical data regarding a patient of a hospital or correctional institution;
(4) Performing therapeutic interventions regarding a patient of a hospital or correctional institution;
(5) Providing information to the appropriate staff of a hospital or correctional institution regarding a chart order submitted by the hospital or correctional institution; and
(6) Providing information regarding the treatment of a patient of a hospital or correctional institution.
(b) "Correctional institution" means any penal facility used for confinement of persons or any facility used for detention of juveniles, which is operated by or under the supervision of a subdivision of the State. The term includes a jail.
(c) "Off-site pharmaceutical service provider" means a pharmacy that provides remote chart order processing services to a hospital or correctional institution that is owned by the same entity as the pharmacy or with which the pharmacy has contracted to provide remote chart order processing services.
(d) "Remote chart order processing services" means chart order processing services provided by an off-site pharmaceutical service provider to a hospital or correctional institution, including, without limitation, transferring information regarding a chart order from the off-site pharmaceutical service provider to members of the staff of the hospital or correctional institution that submitted the chart order.
(Added to NRS by 2023, 658)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.281 - False representations.

1. Any person who secures or attempts to secure any certificate, license or permit issued by the Board for himself or herself or any other person by making, or causing to be made, any false representation or who fraudulently represents himself or herself to be the holder of any certificate, license or permit issued by the Board is guilty of a misdemeanor.
2. Any certificate, license or permit issued by the Board on information later found to be false or fraudulent must be automatically cancelled by the Board.
(Added to NRS by 1967, 1664; A 1989, 1124; 2021, 1021)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2813 - False representation as practitioner or agent; penalties; unauthorized transmission of order for prescription by agent.

1. Except as provided in NRS 453.331 and 454.311, it is unlawful for any person falsely to represent himself or herself as a practitioner entitled to write prescriptions in this state, or the agent of such a person, for the purpose of transmitting to a pharmacist an order for a prescription. A person who violates the provisions of this subsection:
(a) If no substantial bodily harm results, is guilty of a category D felony; or
(b) If substantial bodily harm results, is guilty of a category C felony,
and shall be punished as provided in NRS 193.130.
2. It is unlawful for the agent of a practitioner entitled to write prescriptions in this state willfully to transmit to a pharmacist an order for a prescription if the agent is not authorized by the practitioner to transmit such order.
(Added to NRS by 1979, 342; A 1979, 1697; 1981, 1968; 2013, 2239)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2815 - Fraudulent or excessive charge or claim under program of public assistance; penalty.

A pharmacist or practitioner who knowingly submits to the State or any of its political subdivisions or any agent thereof, a charge or claim for drugs or medical supplies furnished to or for a person receiving medical care under any program of public assistance, which is false or which is in excess of any amount established by law or regulations adopted by the Department of Health and Human Services or by the governing body of any political subdivision, as the price or fee for the furnishing of those drugs or medical supplies, is guilty of a category D felony and shall be punished as provided in NRS 193.130. In addition to any other penalty, the court shall order the person to pay restitution.
(Added to NRS by 1973, 783, 1406; A 1979, 1490; 1989, 1124; 1995, 1312)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.282 - Unlawful possession or sale of certain pharmaceutical preparations, drugs or chemicals; destruction.

1. Except as otherwise provided in NRS 433.801, 435.700, 449.2485, 638.200, 639.267, 639.2675 and 639.2676, it is unlawful for any person to have in his or her possession, or under his or her control, for the purpose of resale, or to sell or offer to sell or dispense or give away, any pharmaceutical preparation, drug or chemical which:
(a) Has been dispensed pursuant to a prescription or chart order and has left the control of a registered pharmacist or practitioner;
(b) Has been damaged or subjected to damage by heat, smoke, fire or water, or other cause which might reasonably render it unfit for human or animal use;
(c) Has been obtained through bankruptcy or foreclosure proceedings, or other court action, auction or other legal or administrative proceedings, except when the pharmaceutical preparation, drug or chemical is in the original sealed container;
(d) Is no longer safe or effective for use, as indicated by the expiration date appearing on its label; or
(e) Has not been properly stored or refrigerated as required by its label.
2. The provisions of subsection 1 do not apply if the person in whose possession the pharmaceutical preparation, drug or chemical is found also has in his or her possession a valid and acceptable certification of analysis attesting to the purity and strength of the pharmaceutical preparation, drug or chemical and attesting to the fact that it can be safely and effectively used by humans or animals. The preparation, drug or chemical must not be sold or otherwise disposed of until the certification required by this subsection has been presented to and approved by the Board.
3. In the absence of conclusive proof that the preparation, drug or chemical can be used safely and effectively by humans or animals, it must be destroyed under the direct supervision of a member or an inspector of the Board, or two persons designated as agents by the Board who include an inspector of a health care board, a licensed practitioner of a health care board or a peace officer of an agency that enforces the provisions of chapters 453 and 454 of NRS.
4. As used in this section, "health care board" includes the State Board of Pharmacy, the State Board of Nursing, the Board of Medical Examiners and the Nevada State Board of Veterinary Medical Examiners.
(Added to NRS by 1967, 1664; A 1979, 982; 1989, 1124, 1450; 2003, 1374; 2009, 1091; 2011, 835; 2013, 3070)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2825 - Unlawful to sell, furnish or fit contact lens; exception.

1. Except as otherwise provided in subsection 2, it is unlawful for the holder of a certificate of registration as a pharmacist, a certificate of registration as an intern pharmacist, a license or a permit granted pursuant to this chapter to sell, furnish or fit a contact lens.
2. A registered pharmacist may, pursuant to a prescription, sell or furnish a prepackaged contact lens that does not require any adjustment, modification or fitting, if:
(a) The prescription includes an expiration date and sets forth the number of refills that the person for whom the contact lens is prescribed may receive; and
(b) The contact lens is not sold or furnished with the intent that the initial use of the contact lens will occur after the expiration date of the prescription.
3. As used in this section, "contact lens" includes, without limitation, any cosmetic or therapeutic contact lens or any contact lens that is used to improve visual acuity.
(Added to NRS by 1985, 876; A 1997, 1259; 1999, 245)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.283 - Use of intoxicating liquor, depressant drug or controlled substance while on duty prohibited; penalty.

Any person who sells, dispenses or compounds any prescription, or sells any drug or poison while under the influence of intoxicating liquor or any depressant drug or controlled substance, unless taken pursuant to a lawfully issued prescription, is guilty of a misdemeanor.
(Added to NRS by 1967, 1664; A 1971, 2043; 1973, 783; 1985, 886; 1989, 1125; 1995, 1714)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.284 - Unlawful dispensing and sales; penalties.

Except as otherwise provided in NRS 639.23277, any person who:
1. Being the licensed proprietor of a pharmacy, fails to place a registered pharmacist in charge of such pharmacy, or permits the compounding or dispensing of drugs or prescriptions, or the selling of drugs, poisons or devices, the sale of which is restricted by the provisions of this chapter, by any person other than a registered pharmacist or an intern pharmacist, is guilty of a misdemeanor.
2. Is not a registered pharmacist and who takes charge of or acts as manager of any pharmacy, compounds or dispenses any prescription, or sells any drug, poison or device, the sale of which is restricted by the provisions of this chapter:
(a) If no substantial bodily harm results, is guilty of a category D felony; or
(b) If substantial bodily harm results, is guilty of a category C felony,
and shall be punished as provided in NRS 193.130.
(Added to NRS by 1967, 1664; A 1975, 204; 2009, 1320; 2013, 2239)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.2845 - Selling or dispensing of procaine hydrochloride.

1. A pharmacist or practitioner is not subject to any penalty for dispensing or selling without a prescription oral doses of procaine hydrochloride with preservatives and stabilizers (Gerovital H3) manufactured in this state.
2. A pharmacist or practitioner who dispenses or sells procaine hydrochloride with preservatives and stabilizers (Gerovital H3) pursuant to this section without a prescription shall maintain a register of persons to whom it was dispensed or sold. The register must contain:
(a) The name and address of the person to whom it was sold or dispensed;
(b) The amount sold or dispensed and the date;
(c) The signature of the person to whom it was sold or dispensed; and
(d) The signature of the dispenser, who must be a registered pharmacist or a registered intern pharmacist acting under the direct and immediate supervision of a registered pharmacist or practitioner.
(Added to NRS by 1983, 337; A 1989, 1125)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.285 - Unlawful sales by unlicensed persons; penalties.

Any person not licensed by the Board, who sells, displays or offers for sale any drug, device or poison, the sale of which is restricted to prescription only or by a registered pharmacist or under his or her direct and immediate supervision:
1. If no substantial bodily harm results, is guilty of a category D felony; or
2. If substantial bodily harm results, is guilty of a category C felony,
and shall be punished as provided in NRS 193.130, unless a greater penalty is provided pursuant to NRS 200.830 or 200.840.
(Added to NRS by 1967, 1665; A 2013, 1000, 2239)
2023 Nevada Revised Statutes › Chapter 639 - Pharmacists and Pharmacy › NRS 639.286 - Violation of Board’s regulations.

Regulations officially adopted by the Board under the powers granted by NRS 454.110 and 639.073 as those regulations apply to the restricted sale of drugs and the sale or labeling of poisons apply to all persons alike. Violation of those regulations is a misdemeanor.
(Added to NRS by 1967, 1665; A 1971, 686; 1979, 1695; 1981, 750; 1985, 370)